Brief: Zoetis Receives Positive Opinion From CVMP For Portela®
12/09/2025 17:52
Sept 12 (Reuters) - Zoetis Inc ZTS.N: ZOETIS RECEIVES POSITIVE OPINION FROM CVMP FOR PORTELA® (RELFOVETMAB) TO ALLEVIATE PAIN ASSOCIATED WITH OSTEOARTHRITIS IN CATS Source text: ID:nBwbZR8Pka Further company coverage: ZTS.N ((((Reuters.Briefs@thomsonreuters.com));))
Recent news on Zoetis
See all newsBrief: Zoetis Receives FDA Approval For Convenia® Rtu For Dogs (Cefovecin Injectable Suspension), Helping More Medium And Large Dogs Access Single-Injection Treatment
Brief: FDA Approves Ready-To-Use Cefovecin Injectable For Treatment Of Certain Skin Infections In Dogs
U.S. RESEARCH ROUNDUP-Masco, Sherwin-Williams, Vulcan Materials
Zoetis gets US FDA emergency use nod for treatment for screwworm in dogs
Brief: FDA Issues Emergency Use Authorization For Simparica Trio To Treat New World Screwworm In Dogs, Puppies